Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies
Denise Obrecht(Universität Hamburg), Stefan Rutkowski(Universität Hamburg), Martin Benesch(St Nicholas Hospital), Robert Kwiecien, Dominik Sturm(German Cancer Research Center), Brigitte Bison(University of Augsburg), Christian Hagel(Universität Hamburg), Gudrun Fleischhack(Essen University Hospital), Nicolas U. Gerber(University Children's Hospital Zurich), Michael Spohn(Centre Hospitalier Universitaire de Clermont-Ferrand), Stefan M. Pfister(Heidelberg University), Torsten Pietsch(University Hospital Bonn), Andreas von Deimling(German Cancer Research Center), Rolf‐Dieter Kortmann(University of Turin), Felix Sahm(German Cancer Research Center), Carsten Friedrich(Klinikum Oldenburg), Ulrich Schüller(Universität Hamburg), Katja von Hoff(Universität Hamburg), Martin Mynarek(Universität Hamburg), Michael Bockmayr(Universität Hamburg), David Jones(German Cancer Research Center), Björn-Ole Juhnke(Universität Hamburg), Rudolf Schwarz(Universität Hamburg), André O. von Bueren(University of Geneva)
Cited by 5
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
|The Lancet Neurology|2020|1.4k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k